ClinicalTrials.gg
CompletedNCT03032237ConsuMEERUpdated Feb 28, 2023

Increase Protein Intake of Older Meal Service Clients With Readymade Protein-rich Meals and Foods

An interventional study of Nutritional intervention - protein-rich and Nutritional intervention - standard in Malnutrition; Protein and Protein Malnutrition, sponsored by HAN University of Applied Sciences. Completed at 1 site in Netherlands. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-02-28.

Sponsored by HAN University of Applied Sciences · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Rationale: Undernutrition risk among community-dwelling older adults in developed countries is shown to be around 24%. Increasing protein intake is a strategy that is feasible as well as efficacious to reduce undernutrition in community-dwelling older adults. A promising strategy to increase protein intake among older adults, is to offer dietary solutions with normal foods that fit their current daily eating patterns. For this reason, home-delivered protein-rich readymade meals and protein-rich dairy products will be studied in this research.

Objective: The primary objective is to study the effectiveness of commercially available protein-rich readymade meals and protein-rich dairy products in increasing protein intake of older adults who use a meal-delivery service to a level of 1.2 g/kg bodyweight/d. Secondary objectives include: studying effects of these meals and dairy products on total daily energy intake. Further, studying the acceptance of and compliance to the meals and dairy products.

Study design: The study will be performed as a single-blind randomized, controlled, four-week trial in a real-life setting: in community-dwelling older adults' own homes.

Study population: The target group of this study are community-dwelling older adults who use a meal-delivery service.

Intervention: Both groups will receive readymade meals for each day during 4 weeks. They will also receive dairy products to freely consume during the intervention period. The intervention groups receives protein-rich meals and protein-rich dairy products, the control receives standard meals and food products.

Main study parameters/endpoints: Difference in daily protein intake between intervention and control group. Secondary parameters: energy intake and acceptance (liking).

02

Conditions studied

  • Malnutrition; Protein
  • Protein Malnutrition

Browse trials for

Keywords

  • Protein intake
  • Older adults
  • Protein-rich
  • Acceptance
  • Liking
  • Readymade meals
03

In context

Kwashiorkor

45 studies on the registry are indexed under Kwashiorkor; 5 are open to participants now.

This study's enrollment of 100 is close to the median of 100 across 33 interventional studies indexed under Kwashiorkor.

Browse Kwashiorkor studies →

Lead sponsor

HAN University of Applied Sciences is the lead sponsor of 7 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 65 years or over
  • Living at home
  • Be a client of maaltijdservice.nl
  • Being able to eat by themselves
  • Have a microwave to heat meals
  • Live in Nijmegen or Den Bosch area
  • Being able to understand, read and speak Dutch
  • Having signed .

Exclusion criteria

Exclusion Criteria:

  • Legally incapacitated
  • (MMSE) score \< 24
  • Following a diet with protein restriction or a vegetarian diet
  • Allergies or intolerances prohibiting the use of dairy products
  • Only using texture modified foods (liquid diet)
  • Diagnosed by doctor with renal insufficiency
  • Suffering from a terminal illness
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Protein-rich assortment

    The intervention groups receives protein-rich meals and protein-rich dairy products.

    Other: Nutritional intervention - protein-rich

  • Placebo comparator
    Standard assortment

    The control group receives standard meals and food products.

    Other: Nutritional intervention - standard

Interventions

  • OtherNutritional intervention - protein-rich

    Both groups will receive readymade meals (Sligro) for each day during the 4-week intervention period (28 hot meals in total per participant). They will also receive other food products from FrieslandCampina's assortment to freely consume during the intervention period. To keep the intervention as close as possible to the real life situation, meals and foods will be home-delivered twice a week as the participants are already used to. Intervention group will receive protein-rich meals and protein-rich foods and drinks.

  • OtherNutritional intervention - standard

    Both groups will receive readymade meals (Sligro) for each day during the 4-week intervention period (28 hot meals in total per participant). They will also receive other food products from FrieslandCampina's assortment to freely consume during the intervention period. To keep the intervention as close as possible to the real life situation, meals and foods will be home-delivered twice a week as the participants are already used to. Control group will receive standard (not protein-rich) meals and standard foods and drinks.

06

What researchers measure

Primary outcomes

  1. Protein intake

    Difference in daily protein intake between intervention and control group assessed with 3-day food records which will be checked by trained dietitians.

    Time frame: 4 weeks

Secondary outcomes

  1. Acceptance

    Acceptance and liking of meals and food products; outcome will be measured with a questionnaire including a 5-point likert scale (for liking) and a question how much was eaten. This questionnaire needs to be done every day.

    Time frame: 4 weeks

  2. Energy intake

    Difference in daily energy intake between intervention and control group assessed with 3-day food records which will be checked by trained dietitians.

    Time frame: 4 weeks

07

Study locations

1 site
  • HAN University of Applied Sciences
    Nijmegen, Netherlands
08

References and documents

Individual participant data

Plan to share: No — IPD will not be shared.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2017 to primary completion in May 2017, 1 month.

Of 21 interventional studies with no phase under Kwashiorkor, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 24. This study's 1 month is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 16, 2017
First posted
Jan 26, 2017
StartActual
Apr 4, 2017
Primary completionActual
May 31, 2017
CompletionActual
May 31, 2017
Last update
Feb 28, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03032237
Lead sponsor
HAN University of Applied Sciences
Collaborators
HAS Hogeschool, Centre of Expertise Food (CoE Food), Sligro, FrieslandCampina
Responsible party
dr. Marian de van der Schueren (Prof. Dr., HAN University of Applied Sciences) — Principal investigator
First posted
Jan 26, 2017
Start date
Apr 4, 2017
Primary completion
May 31, 2017
Completion
May 31, 2017
Last update
Feb 28, 2023

Study contacts

Marian de van der Schueren, PhD
principal investigator · HAN University of Applied Sciences
Annet Roodenburg, PhD
principal investigator · HAS Hogeschool

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion